Swedencare AB (publ) (SECARE) Q2 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

margin and operating cash flow improved to 78 million SEK. Looking at our three segments, the growth profile is clearly mixed. Europe and production were really strong with organic growth of 19 and 25% respectively, while North America was down 3% organically due mainly to delayed FDMC or big box launch deliveries and temporary effects in the US veterinary channel. However, the North American segment would have been around middle single digit without this and that is still not where we should be. So improvements to come. Export markets delivered their strongest quarter to date with China rebounding sharply. End of quarter I visited China and we are planning to widen the production offering of protein black golf. and are also looking at the opportunities to launch more brands there. The interest is high, but the regulatory framework for imports is complicated, and we are now in discussions with potential manufacturing partners to facilitate new brand launches. Proden Packoff had another exceptional quarter and delivered more than 30% growth. Pharma delivers as expected, high growth numbers, both in manufacturing and development. and the activity level is high for the years to come. Strategically, the quarter also moved the business forward with new offerings, product offerings from under many of our brands and corporations and product launches. Interzoo was also an important event, of course, it's every second year. the biggest trade show in the world. So new market is opening up for Pearl and Black Off, of course, new smaller markets since we're already present in plus 60 countries, but really nice to see new opportunities there. And for other group brands, some big opportunities are in discussions with the relevant distributors. We also had the first capital markets...